Delivery Order SPE2DB20D3303-SPE2DB25FA3PQ
Award Date 9/11/25
Potential Completion Date 9/12/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,852.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B PEDI 10 MCG/0.5 ML syringes, a pediatric hepatitis B vaccine. This non-competitive delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a routine pharmaceutical procurement under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,416.30 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded a $5,233.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B PEDI 10 MCG/0.5 syringe in 0.5 milliliter units. This pediatric hepatitis B vaccine delivery order was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a non-competitive, non-set-aside transaction issued under an existing contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for $1,416.30 to supply ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $4,248.90 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of ENGERIX-B PEDI 10 MCG/0.5 syringe vaccine products. This is a firm fixed price delivery order with an ultimate completion date of September 5, 2025, and represents a pediatric hepatitis B vaccine procurement for federal medical supply needs. The contract carries no set-aside designation and was competitively awarded through open procurement channels....
- The Defense Logistics Agency awarded a delivery order valued at $1,751.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,925.92 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a firm fixed-price procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 14, 2025, for the supply of ENGERIX-B PEDI 10 MCG/0.5 ml syringes, a pediatric hepatitis B vaccine. This firm fixed-price delivery order, valued at $3,057.06, represents a non-competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract is scheduled for completion by September 15, 2025, with performance taking place at...
- The Defense Logistics Agency awarded a $1,751.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for ENGERIX-B 20 MCG/ML vaccine syringes. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $2,124.45 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B PEDI 10 MCG/0.5 ml syringes on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used in pediatric immunization...